Design and synthesis of novel Y-shaped barbituric acid derivatives as PPARγ activators-Reference-Cited by-同舟云学术

Design and synthesis of novel Y-shaped barbituric acid derivatives as PPARγ activators

Published:2016-01 Issue: Volume:108 Page:423-435
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Dixit Vaibhav A.^ORCID,Rathi Prakash Chandra,Bhagat Shweta,Gohlke Holger,Petersen Rasmus K.,Kristiansen Karsten,Chakraborti Asit K.,Bharatam Prasad V.

Funder

UGC

CSIR

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference104 articles.

1. Studies on antidiabetic agents. VI. Asymmetric transformation of (.+-.)-5-(4-(1-methylcyclohexylmethoxy)benzyl)-2,4-thiazolidinedione(ciglitazone) with optically active 1-phenylethylamines.

2. Lessons from the glitazones: a story of drug development

3. Mechanisms of Troglitazone Hepatotoxicity

4. Thiazolidinedione Bioactivation: A Comparison of the Bioactivation Potentials of Troglitazone, Rosiglitazone, and Pioglitazone Using Stable Isotope-Labeled Analogues and Liquid Chromatography Tandem Mass Spectrometry

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practice of green chemistry strategies in synthetic organic chemistry: a glimpse of our sincere efforts in green chemistry research;Chemical Communications;2024

2. Crystal structures of non-uracil ring fragments in complex with Mycobacterium tuberculosis uracil DNA glycosylase (MtUng) as a starting point for novel inhibitor design: A case study with the barbituric acid fragment;European Journal of Medicinal Chemistry;2023-10

3. Discovery of 5-(3,4-dihydroxybenzylidene)-1,3-dimethylpyrimidine- 2,4,6(1H,3H,5H)-trione as a novel and effective cardioprotective agent via dual anti-inflammatory and anti-oxidative activities;European Journal of Medicinal Chemistry;2022-12

4. Development of Heterocyclic PPAR Ligands for Potential Therapeutic Applications;Pharmaceutics;2022-10-08

5. Recent Advances on the Role of Nitrogen‐Based Heterocyclic Scaffolds in Targeting HIV through Reverse Transcriptase Inhibition;ChemistrySelect;2022-09-22